1. Executive Summary 2. Global Total Market Value of the Top 20 Vaccine Companies (2015 – 2019) 3. Market Share Analysis of the Top 20 Vaccine Companies (%) 4. Key Market Drivers and Inhibitors in the Vaccine Market 4.1 Key Market Drivers 4.2 Key Market Inhibitors 5. Major Deals and Agreement Happenings in the Vaccine Market 5.1 Merger & Acquisitions 5.2 Collaboration Deals 5.3 Licensing Agreement 5.4 Exclusive Agreement 5.5 Distribution Agreement 5.6 Partnership Deals 6. Top 20 Vaccine Companies in the Vaccine Market 6.1 Sanofi Pasteur 6.1.1 Business Overview 6.1.2 Vaccines Portfolio 6.1.3 Vaccines Market Value Analysis 6.1.4 Promising Vaccines in the Clinical Development 6.1.5 Recent Development 6.2 GlaxoSmithKline (GSK) 6.2.1 Business Overview 6.2.2 Vaccines Portfolio 6.2.3 Vaccines Market Value Analysis 6.2.4 Promising Vaccines in the Clinical Development 6.2.5 Recent Development 6.3 Merck & Co., Inc. 6.3.1 Business Overview 6.3.2 Vaccines Portfolio 6.3.3 Vaccines Market Value Analysis 6.3.4 Promising Vaccines in the Clinical Development 6.3.5 Recent Development 6.4 Pfizer 6.4.1 Business Overview 6.4.2 Vaccines Portfolio 6.4.3 Vaccines Market Value Analysis 6.4.4 Promising Vaccines in the Clinical Development 6.4.5 Recent Development 6.5 AstraZeneca 6.5.1 Business Overview 6.5.2 Vaccines Portfolio 6.5.3 Vaccines Market Value Analysis 6.5.4 Recent Development 6.6 Mitsubishi Tanabe Pharma 6.6.1 Business Overview 6.6.2 Vaccines Portfolio 6.6.3 Vaccines Market Value Analysis 6.6.4 Promising Vaccines in the Clinical Development 6.6.5 Recent Development 6.7 Emergent BioSolutions 6.7.1 Business Overview 6.7.2 Vaccines Portfolio 6.7.3 Vaccines Market Value Analysis 6.7.4 Promising Vaccines in the Clinical Development 6.7.5 Recent Development 6.8 Astlellas Pharma Inc 6.8.1 Business Overview 6.8.2 Vaccines Portfolio 6.8.3 Vaccines Market Value Analysis 6.8.4 Recent Development 6.9 Valneva 6.9.1 Business Overview 6.9.2 Vaccines Portfolio 6.9.3 Vaccines Market Value Analysis 6.9.4 Promising Vaccines in the Clinical Development 6.9.5 Recent Development 6.10 Seqirus (CSL Limited) 6.10.1 Business Overview 6.10.2 Vaccines Portfolio 6.10.3 Vaccines Market Value Analysis 6.10.4 Promising Vaccines in the Clinical Development 6.10.5 Recent Development 6.11 Bavarian Nordic 6.11.1 Business Overview 6.11.2 Vaccines Portfolio 6.11.3 Vaccines Market Value Analysis 6.11.4 Promising Vaccines in the Clinical Development 6.11.5 Recent Development 6.12 Sinovac 6.12.1 Business Overview 6.12.2 Vaccines Portfolio 6.12.3 Vaccines Market Value Analysis 6.12.4 Promising Vaccines in the Clinical Development 6.12.5 Recent Development 6.13 Panacea Biotec 6.13.1 Business Overview 6.13.2 Vaccines Portfolio 6.13.3 Vaccines Market Value Analysis 6.13.4 Promising Vaccines in the Clinical Development 6.13.5 Recent Development 6.14 Dynavax Technologies Corporation 6.14.1 Business Overview 6.14.2 Vaccines Portfolio 6.14.3 Vaccines Market Value Analysis 6.14.4 Promising Vaccines in the Clinical Development 6.14.5 Recent Development 6.15 Bharat Biotech 6.15.1 Business Overview 6.15.2 Vaccines Portfolio 6.15.3 Promising Vaccines in the Clinical Development 6.15.4 Recent Development 6.16 Serum Institute of India 6.16.1 Business Overview 6.16.2 Vaccines Portfolio 6.16.3 Promising Vaccines in Clinical Development 6.16.4 Recent Development 6.17 Biological E. Limited 6.17.1 Business Overview 6.17.2 Vaccines Portfolio 6.17.3 Promising Vaccines in the Clinical Development 6.17.4 Recent Development 6.18 Grifols 6.18.1 Business Overview 6.18.2 Vaccines Portfolio 6.18.3 Recent Development 6.19 Hualan Biological Engineering Inc 6.19.1 Business Overview 6.19.2 Influenza Vaccines Portfolio 6.19.3 Recent Development 6.20 Gamma Vaccines Pty Ltd 6.20.1 Business Overview 6.20.2 Influenza Vaccines Portfolio 6.20.3 Recent Development

List of Tables: Table 5–1: Merger & Acquisitions in the Vaccine Market Table 5–2: Collaboration Deals in the Vaccine Market Table 5–3: Licensing Agreement in the Vaccine Market Table 5–4: Exclusive Agreement in the Vaccine Market Table 5–5: Distribution Agreement in the Vaccine Market Table 5–6: Partnership Deals in the Vaccine Market Table 6–1: Sanofi Promising Vaccines in the Clinical Development Table 6–2: GSK Promising Vaccines in the Clinical Development Table 6–3: Merck Promising Vaccines in the Clinical Development Table 6–4: Pfizer Promising Vaccines in the Clinical Development Table 6–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development Table 6–6: Emergent Biosolutions Promising Vaccines in the Clinical Development Table 6–7: Valneva Promising Vaccines in the Clinical Development Table 6–8: Seqirus Promising Vaccines in the Clinical Development Table 6–9: Bavarian Nordic Promising Vaccines in the Clinical Development Table 6–10: Sinovac Promising Vaccines in the Clinical Development Table 6–11: Panacea Biotec Promising Vaccines in the Clinical Development Table 6–12: Dynavax Technologies Corporation Promising Vaccines in the Clinical Development Table 6–13: Bharat Biotech Promising Vaccines in the Clinical Development List of Figures: Figure 2–1: Global Top 20 Vaccine Companies Sales Value (Million US$),2015 – 2019 Figure 3–1: Market Share Analysis of the Top 20 Vaccine Companies (Percent), 2019 Figure 6–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–2: GSK Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–3: Merck Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–4: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–5: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 6–6: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 6–7: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–8: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 6–9: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–10: Seqirus Vaccines Market Value Analysis (Million US$),2015 - 2019 Figure 6–11: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–12: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–13: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2019 Figure 6–14: Dynavax Vaccines Market Value Analysis (Million US$),2018 – 2019